SEC Filing Summary: Nephros, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on July 17, 2006. The report addresses a notice received from the American Stock Exchange (AMEX) regarding the Company's compliance with continued listing standards based on its Form 10-QSB for the quarter ended March 31, 2006.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it references the following financial conditions cited by the AMEX as grounds for non-compliance:
- Shareholders' Equity: Less than $4,000,000 (violating Section 1003(a)(ii)) and less than $6,000,000 (violating Section 1003(a)(iii)).
- Net Losses: The Company reported losses from continuing operations and/or net losses in three of its four most recent fiscal years and in its five most recent fiscal years.
Material Changes and Listing Status
The primary material event is the notice of failure to satisfy AMEX continued listing standards. Specifically, the Company failed to meet equity and profitability thresholds. As of the filing date, the Company's common stock continues to trade on the AMEX, but it is under review for potential delisting.
Outlook, Management Commentary, and Risks
Compliance Plan: To maintain its listing, Nephros, Inc. must submit a compliance plan to the AMEX by August 17, 2006. This plan must detail actions taken or planned to achieve compliance by January 17, 2008.
Plan Period: If the AMEX accepts the plan, the Company may remain listed for up to eighteen months, subject to periodic progress reviews.
Risks: If the AMEX rejects the plan, or if the Company fails to make progress consistent with the plan or achieve compliance by the end of the plan period, the AMEX may initiate delisting proceedings.
Key Facts for Investor Verification
- Verify the specific shareholders' equity and net loss figures in the Form 10-QSB for the quarter ended March 31, 2006.
- Monitor the submission of the compliance plan by the August 17, 2006 deadline.
- Track the AMEX's decision on the acceptance of the compliance plan.
- Review subsequent filings for progress reports during the potential 18-month plan period.